Estelle Bastien

1.4k total citations · 1 hit paper
17 papers, 1.0k citations indexed

About

Estelle Bastien is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Biomedical Engineering. According to data from OpenAlex, Estelle Bastien has authored 17 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 6 papers in Pulmonary and Respiratory Medicine and 6 papers in Biomedical Engineering. Recurrent topics in Estelle Bastien's work include Nanoplatforms for cancer theranostics (6 papers), Cancer, Hypoxia, and Metabolism (5 papers) and Photodynamic Therapy Research Studies (5 papers). Estelle Bastien is often cited by papers focused on Nanoplatforms for cancer theranostics (6 papers), Cancer, Hypoxia, and Metabolism (5 papers) and Photodynamic Therapy Research Studies (5 papers). Estelle Bastien collaborates with scholars based in Belgium, France and Germany. Estelle Bastien's co-authors include Olivier Féron, Cyril Corbet, Céline Guilbaud, Chantal Dessy, Emeline Dierge, Yvan Larondelle, Bastien Doix, Éric Mignolet, Ruben Martherus and Henri‐Pierre Lassalle and has published in prestigious journals such as Journal of the American Chemical Society, Nature Communications and Cell Metabolism.

In The Last Decade

Estelle Bastien

17 papers receiving 1.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Peroxidation of n-3 and n-6 polyunsaturated fatty acids in the acidic tumor environment leads to ferroptosis-mediated anticancer effects

2021 328 citations Emeline Dierge, Céline Guilbaud et al. Cell Metabolism profile →

Peers

Countries citing papers authored by Estelle Bastien

Since Specialization

Citations

This map shows the geographic impact of Estelle Bastien's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Estelle Bastien with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Estelle Bastien more than expected).

Fields of papers citing papers by Estelle Bastien

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Estelle Bastien. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Estelle Bastien. The network helps show where Estelle Bastien may publish in the future.

Co-authorship network of co-authors of Estelle Bastien

This figure shows the co-authorship network connecting the top 25 collaborators of Estelle Bastien. A scholar is included among the top collaborators of Estelle Bastien based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Estelle Bastien. Estelle Bastien is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

#	Work	Indexed citations
1	319TiP NeoBREASTIM: A phase II study of atezolizumab plus RP1 oncolytic immunotherapy in the neoadjuvant setting of triple-negative breast cancer (TNBC) 2024 ·Annals of Oncology ·Estelle Bastien, (unknown), (unknown), (unknown), Delphine Loirat, Marie‐Paule Sablin, Anne Vincent‐Salomon, (unknown), (unknown), Caroline Malhaire, Alexia Savignoni, Emanuela Romano	1
2	Optogenetically controlled inflammasome activation demonstrates two phases of cell swelling during pyroptosis 2024 ·Science Signaling ·Julien Nadjar, Sylvain Monnier, Estelle Bastien, Anne‐Laure Huber, Christiane Oddou, (unknown), (unknown), Gabriel Ichim, Christophe Vanbelle, Bénédicte F. Py, Olivier Destaing, Virginie Pétrilli	4
3	Tumor acidosis-induced DNA damage response and tetraploidy enhance sensitivity to ATM and ATR inhibitors 2024 ·EMBO Reports ·Léo Aubert, Estelle Bastien, Ophélie Renoult, Céline Guilbaud, (unknown), Davide Brusa, Caroline Bouzin, (unknown), Corentin Richard, Romain Boidot, Daniel Léonard, Cyril Corbet, Olivier Féron	5
4	3D evaluation of the extracellular matrix of hypoxic pancreatic islets using light sheet fluorescence microscopy 2024 ·Islets ·(unknown), Estelle Bastien, Heeyoung Chae, Pierre Gianello, Patrick Gilon, Caroline Bouzin	2
5	Peroxidation of n-3 and n-6 polyunsaturated fatty acids in the acidic tumor environment leads to ferroptosis-mediated anticancer effects breakdown → 2021 ·Cell Metabolism ·Emeline Dierge, (unknown), Céline Guilbaud, Cyril Corbet, Éric Mignolet, (unknown), Estelle Bastien, Chantal Dessy, Yvan Larondelle, Olivier Féron	328
6	Therapy-induced DNA methylation inactivates MCT1 and renders tumor cells vulnerable to MCT4 inhibition 2021 ·Cell Reports ·(unknown), Cyril Corbet, Estelle Bastien, Ruben Martherus, Céline Guilbaud, (unknown), (unknown), Axelle Loriot, Charles De Smet, Olivier Féron	26
7	TGFβ2-induced formation of lipid droplets supports acidosis-driven EMT and the metastatic spreading of cancer cells 2020 ·Nature Communications ·Cyril Corbet, Estelle Bastien, Joaquim Tiago Cardoso Leles de Jesus, Emeline Dierge, Ruben Martherus, (unknown), Bastien Doix, Charline Degavre, Céline Guilbaud, (unknown), Carine Michiels, Chantal Dessy, Yvan Larondelle, Olivier Féron	208
8	Inhibition of colorectal cancer-associated fibroblasts by lipid nanocapsules loaded with acriflavine or paclitaxel 2020 ·International Journal of Pharmaceutics ·Thibaut Fourniols, Estelle Bastien, (unknown), Olivier Féron, Véronique Préat	22
9	Obesity and triple‐negative‐breast‐cancer: Is apelin a new key target? 2020 ·Journal of Cellular and Molecular Medicine ·(unknown), Lionel Mignion, Matthias Van Hul, (unknown), Estelle Bastien, Valéry L. Payen, Baptiste Leroy, Nicolas Joudiou, Didier Vertommen, Caroline Bouzin, Nathalie M. Delzenne, Bernard Gallez, Olivier Féron, Bénédicte F. Jordan, Patrice D. Cani	21
10	Exploring the Phototoxicity of Hypoxic Active Iridium(III)-Based Sensitizers in 3D Tumor Spheroids 2019 ·Journal of the American Chemical Society ·Robin Bevernaegie, Bastien Doix, Estelle Bastien, Aurélie Diman, Anabelle Decottignies, Olivier Féron, Benjamin Elias	103
11	Preclinical Evaluation of White Led-Activated Non-porphyrinic Photosensitizer OR141 in 3D Tumor Spheroids and Mouse Skin Lesions 2018 ·Frontiers in Oncology ·Bastien Doix, Estelle Bastien, (unknown), Adán Pinto, Caroline Louis, Vincent Grégoire, Olivier Riant, Olivier Féron	14
12	Antidiabetic Biguanides Radiosensitize Hypoxic Colorectal Cancer Cells Through a Decrease in Oxygen Consumption 2018 ·Frontiers in Pharmacology ·Sven de Mey, Heng Jiang, Cyril Corbet, Hui Wang, Inès Dufait, Lun Law Ka, Estelle Bastien, Valeri N. Verovski, Thierry Gevaert, Olivier Féron, Mark De Ridder	32
13	Interruption of lactate uptake by inhibiting mitochondrial pyruvate transport unravels direct antitumor and radiosensitizing effects 2018 ·Nature Communications ·Cyril Corbet, Estelle Bastien, Nihed Draoui, Bastien Doix, Lionel Mignion, Bénédicte F. Jordan, Arnaud Marchand, Jean‐Christophe Vanherck, Patrick Chaltin, Olivier Schakman, Holger M. Becker, Olivier Riant, Olivier Féron	145
14	5-Aminolevulinic Acid-Squalene Nanoassemblies for Tumor Photodetection and Therapy: In Vitro Studies 2018 ·Nanoscale Research Letters ·(unknown), (unknown), Estelle Bastien, Henri‐Pierre Lassalle, Lina Bezdetnaya, Norbert Lange	24
15	Prospects of in vivo singlet oxygen luminescence monitoring: Kinetics at different locations on living mice 2016 ·Photodiagnosis and Photodynamic Therapy ·(unknown), Jan C. Schlothauer, Estelle Bastien, Steffen Hackbarth, Lina Bezdetnaya, Henri‐Pierre Lassalle, Beate Röder	17
16	Inclusion complexation with β-cyclodextrin derivatives alters photodynamic activity and biodistribution of meta-tetra(hydroxyphenyl)chlorin 2016 ·European Journal of Pharmaceutical Sciences ·(unknown), Estelle Bastien, Ilya Yakavets, (unknown), Henri‐Pierre Lassalle, Susanna Gräfe, Lina Bezdetnaya, Vladimir Zorin	34
17	PAMAM G4.5-chlorin e6 dendrimeric nanoparticles for enhanced photodynamic effects 2015 ·Photochemical & Photobiological Sciences ·Estelle Bastien, Raphaël Schneider, Steffen Hackbarth, Dominique Dumas, Jordane Jasniewski, Beate Röder, Lina Bezdetnaya, Henri‐Pierre Lassalle	35

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact